+19.3%
MRNA vs SN
+496.6%
-477.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | +1.0% | -4.6% | -3.8% |
| 7D | -9.0% | +0.1% | -9.2% | -9.1% |
| 30D | +137.2% | -5.6% | +142.8% | +138.7% |
| 3M | +194.8% | +48.1% | +146.7% | +167.6% |
| 6M | +167.2% | +57.6% | +109.6% | +138.3% |
| YTD | +375.9% | +56.5% | +319.4% | +323.4% |
| 1Y | +465.2% | +52.6% | +412.6% | +404.2% |
| 3Y | +30.4% | +412.0% | -381.6% | +4.6% |
| All | +19.3% | +496.6% | -477.4% | -4.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling